The latest news from Arcinova
July 22, 2020
Gareth Jenkins presenting at "Reopening laboratories: sharing best practice"
Gareth Jenkins presenting at "Reopening laboratories: sharing best practice" About this Event The nationwide lockdown due to the spread of COVID saw an impressive
July 16, 2020
Arcinova appoints new Non-Executive Director
Arcinova appoints new Non-Executive Director “Internationally renowned Industry veteran Steve Bagshaw joins Arcinova board to propel continued industry-leading growth” Arcinova
July 16, 2020
Nathalie Huther Featured In European Biotechnology Magazine_a
Nathalie Huther Featured In European Biotechnology Magazine Did you see Nathalie’s quote on why she chose to work in Biotechnology in the latest summer edition of
July 9, 2020
The Growing Popularity of Capsule Manufacturing in Pharma
Our Head of Drug Product and Scientific Direction, Steve Byard, recently shared his thoughts on the benefits of capsule manufacturing. In his article for PMPS, Steve explains the factors that must
June 23, 2020
OBN Events in conjunction with Arcinova presents "The Need for Speed: Gaining the right support to accelerate your small molecule candidate"
OBN Events in conjunction with Arcinova presents "The Need for Speed: Gaining the right support to accelerate your small molecule candidate" About the EventThis digi
June 4, 2020
Dr. Nathalie Huther interviewed for Chemicals Knowledge Hub TV
Our Senior Director of Business Development Europe, Dr. Nathalie Huther, was recently interviewed by journalist and presenter, David McClelland, for Chemicals Knowledge Hub TV! Watch the video to
June 1, 2020
Revving Up for the Revolution: Industry 4.0
Revving Up for the Revolution: Industry 4.0 “The current change – from the third to the fourth industrial revolution – is marked by a move toward a consolidated, full-spectrum, data-driven a
June 1, 2020
Register now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical success
Register now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical success Preformulation characterization of new chemical entities (NCE) can be c
June 1, 2020
Paul Quigley joins advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product
We are thrilled to announce that our Head of Drug Substance, Paul Quigley, has been invited to join the advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product.Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.
